Get started
ASTRAZENECA PLC ORD USD0.25ASTRAZENECA PLC ORD USD0.25ASTRAZENECA PLC ORD USD0.25

ASTRAZENECA PLC ORD USD0.25

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

AZN chart


Full chart

Key facts today

AstraZeneca's Tagrisso has received European Commission approval for treating advanced non-small cell lung cancer, showing a median progression-free survival of over three years in late-stage trials.
The FDA revoked the emergency use authorization for AstraZeneca's Evusheld due to its expired shelf life and lack of patient administration approval for over a year.
Analyze the impactAnalyze the impact

AZN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪159.00 B‬ GBP
Dividend yield (indicated)
2.28%
Price to earnings Ratio (TTM)
32
Basic EPS (TTM)
4 GBP
Net income (FY)
‪4.79 B‬ GBP
Revenue (FY)
‪36.85 B‬ GBP
Shares float
‪1.47 B‬
Beta (1Y)
1.28

Employees


Employees (FY)
‪89.9 K‬
Change (1Y)
‪+6.4 K‬ +7.66%
Revenue / Employee (1Y)
‪409.94 K‬ GBP
Net income / Employee (1Y)
‪53.29 K‬ GBP

About ASTRAZENECA PLC ORD USD0.25


Sector
Health Technology
CEO
Pascal Soriot
Headquarters
Cambridge
Website
astrazeneca.co.uk
Founded
1992
ISIN
GB0009895292
FIGI
BBG000C0YGH4
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AZN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AZN highest yielding bonds


US46353AX6
ASTRAZENECA 20/50
Yield to maturity
7.19%
Maturity date
Aug 6, 2050
US46353AZ1
ASTRAZENECA 21/51
Yield to maturity
6.54%
Maturity date
May 28, 2051
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
6.03%
Maturity date
Sep 18, 2042
US46353AM0
ASTRAZENECA PLC 15/45
Yield to maturity
5.92%
Maturity date
Nov 16, 2045
US46353AU2
ASTRAZENECA 18/48
Yield to maturity
5.91%
Maturity date
Aug 17, 2048
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
5.41%
Maturity date
Sep 15, 2037
A
AZN5193314
AstraZeneca Finance LLC 2.25% 28-MAY-2031
Yield to maturity
5.39%
Maturity date
May 28, 2031
US46353AW8
ASTRAZENECA 20/30
Yield to maturity
5.32%
Maturity date
Aug 6, 2030
A
US4636NAN3
ASTRAZEN.FI. 24/34
Yield to maturity
5.19%
Maturity date
Feb 26, 2034
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
5.10%
Maturity date
Mar 3, 2033
A
AZN5193317
AstraZeneca Finance LLC 1.75% 28-MAY-2028
Yield to maturity
4.98%
Maturity date
May 28, 2028

Explore more bonds 

Sparks


Curated watchlists where AZN is featured.

See all sparks 

Frequently Asked Questions


The current price of AZN is 10,436 GBX — it has increased by 1.62% in the past 24 hours. Watch ASTRAZENECA PLC ORD USD0.25 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ASTRAZENECA PLC ORD USD0.25 stocks are traded under the ticker AZN.
AZN stock has fallen by −0.93% compared to the previous week, the month change is a 2.34% rise, over the last year ASTRAZENECA PLC ORD USD0.25 has showed a 0.83% increase.
We've gathered analysts' opinions on ASTRAZENECA PLC ORD USD0.25 future price: according to them, AZN price has a max estimate of 18,247.00 GBX and a min estimate of 10,599.81 GBX. Watch AZN chart and read a more detailed ASTRAZENECA PLC ORD USD0.25 stock forecast: see what analysts think of ASTRAZENECA PLC ORD USD0.25 and suggest that you do with its stocks.
AZN reached its all-time high on Sep 3, 2024 with the price of 13,388 GBX, and its all-time low was 1,744 GBX and was reached on Mar 17, 2008. View more price dynamics on AZN chart.
See other stocks reaching their highest and lowest prices.
AZN stock is 0.73% volatile and has beta coefficient of 1.28. Track ASTRAZENECA PLC ORD USD0.25 stock price on the chart and check out the list of the most volatile stocks — is ASTRAZENECA PLC ORD USD0.25 there?
Today ASTRAZENECA PLC ORD USD0.25 has the market capitalization of ‪161.57 B‬, it has decreased by −0.30% over the last week.
Yes, you can track ASTRAZENECA PLC ORD USD0.25 financials in yearly and quarterly reports right on TradingView.
ASTRAZENECA PLC ORD USD0.25 is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
AZN earnings for the last quarter are 1.56 GBX per share, whereas the estimation was 1.53 GBX resulting in a 1.83% surprise. The estimated earnings for the next quarter are 1.70 GBX per share. See more details about ASTRAZENECA PLC ORD USD0.25 earnings.
ASTRAZENECA PLC ORD USD0.25 revenue for the last quarter amounts to ‪10.14 B‬ GBX, despite the estimated figure of ‪9.78 B‬ GBX. In the next quarter, revenue is expected to reach ‪11.29 B‬ GBX.
AZN net income for the last quarter is ‪1.10 B‬ GBP, while the quarter before that showed ‪1.53 B‬ GBP of net income which accounts for −28.03% change. Track more ASTRAZENECA PLC ORD USD0.25 financial stats to get the full picture.
ASTRAZENECA PLC ORD USD0.25 dividend yield was 2.15% in 2023, and payout ratio reached 73.66%. The year before the numbers were 2.13% and 138.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has ‪89.90 K‬ employees. See our rating of the largest employees — is ASTRAZENECA PLC ORD USD0.25 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASTRAZENECA PLC ORD USD0.25 EBITDA is ‪12.46 B‬ GBP, and current EBITDA margin is 31.31%. See more stats in ASTRAZENECA PLC ORD USD0.25 financial statements.
Like other stocks, AZN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASTRAZENECA PLC ORD USD0.25 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASTRAZENECA PLC ORD USD0.25 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASTRAZENECA PLC ORD USD0.25 stock shows the neutral signal. See more of ASTRAZENECA PLC ORD USD0.25 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.